The aim of this study is to improve knowledge of natural history and methods of monitoring the evolution of Glycogen storage disease type III regarding the muscle and to study the prospective approach of large series of patients, and using the same protocol for the follow up of the children and adults.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
30
Time to rise from a chair, time to go from lying to sitting, time to go from lying to standing, time to cover 10 meters, time to climb 4 steps
Purdue pegboard test
Institut de Myologie
Paris, France
RECRUITINGKnee flexion and extension strength
Time frame: at baseline
Knee flexion and extension strength
Time frame: 2 years after baseline
Knee flexion and extension strength
Time frame: 4 years after baseline
Time to perform each motor function test
Time frame: at baseline
Time to perform each motor function test
Time frame: 2 years after baseline
Time to perform each motor function test
Time frame: 4 years after baseline
Gait speed measured during the 6 minutes walk test
Time frame: at baseline
Gait speed measured during the 6 minutes walk test
Time frame: 2 years after baseline
Gait speed measured during the 6 minutes walk test
Time frame: 4 years after baseline
Accelerometric variables measured for the 6 minutes walk test
Time frame: At baseline
Accelerometric variables measured for the 6 minutes walk test
Time frame: 2 years after baseline
Accelerometric variables measured for the 6 minutes walk test
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 4 years after baseline
NMR variables measured during each specific NMR sequence
Time frame: at baseline
NMR variables measured during each specific NMR sequence
Time frame: 2 years after baseline
NMR variables measured during each specific NMR sequence
Time frame: 4 years after baseline